Safe Prescribing for Women of Reproductive Age
The use of potentially teratogenic medications is a significant public health issue that affects millions of families each year. Despite challenges that include limited data and competing clinical tasks, safe prescribing for women of reproductive age should be a national priority. There are ample opportunities in research, medical education, clinical practice and health policy to improve care for women of reproductive age who are taking or considering taking teratogenic medications. With increased attention to this issue, clinicians and policy-makers can help promote healthy pregnancies and healthy lives.
Conclusion
The use of potentially teratogenic medications is a significant public health issue that affects millions of families each year. Despite challenges that include limited data and competing clinical tasks, safe prescribing for women of reproductive age should be a national priority. There are ample opportunities in research, medical education, clinical practice and health policy to improve care for women of reproductive age who are taking or considering taking teratogenic medications. With increased attention to this issue, clinicians and policy-makers can help promote healthy pregnancies and healthy lives.